Prevail Therapeutics's - PRVL market analysis on 28th November 2020

Transaction Date	Recipient	Shares	Type	Price	Value
17th November 2020	Advisors Llc Orbimed	868,016	Exercise of in-the-money or at-the-money derivatives securities (usually options)	$0.01	$8,680.16
17th November 2020	Advisors Llc Orbimed	765,992	Exercise of in-the-money or at-the-money derivatives securities (usually options)	$0.01	$7,659.92
17th November 2020	Advisors Llc Orbimed	434,008	Exercise of in-the-money or at-the-money derivatives securities (usually options)	$0.01	$4,340.08
17th November 2020	Advisors Llc Orbimed	434,008	Exercise of in-the-money or at-the-money derivatives securities (usually options)	$0.01	$4,340.08
17th November 2020	Advisors Llc Orbimed	1,531,984	Exercise of in-the-money or at-the-money derivatives securities (usually options)	$0.01	$15,319.84
17th November 2020	Advisors Llc Orbimed	765,992	Exercise of in-the-money or at-the-money derivatives securities (usually options)	$0.01	$7,659.92
2nd October 2020	Advisors Llc Orbimed	200,000	Open or private purchase	$25.00	$5,000,000.00
2nd October 2020	Advisors Llc Orbimed	296,000	Open or private purchase	$25.00	$7,400,000.00
1st October 2020	Advisors Llc Orbimed	296,296	Open or private purchase	$6.00	$1,777,776.00
1st October 2020	Advisors Llc Orbimed	46,784,775	Grant/award etc.	$1.07	$50,059,709.25

Prevail Therapeutics

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY.

Ticker: PRVL

Sector: Health Technology

Industry: Biotechnology

SEC Central Index Key (CIK): 1714798

Employees: 55

Exchange: NASDAQ

Auditor Opinion:

You must Login to see Language Changes

Disclosure Language changes

Analysis of subtle changes in disclosure language. Red is a sign of more constrained, less positive language changes etc. Green is more positive, less constrained etc.

You must Login to see analysis